PTC Therapeutics, Inc(NASDAQ:PTCT) 
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for the treatment of rare disorders. The company offers Translarna (ataluren) and Emflaza (deflazacort) for the treatment of nonsense mutation Duchenne muscular dystrophy in...
Website: http://www.ptcbio.com
Founded: 1998
Full Time Employees: 754
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 45.44
H 46.16
L 42.98
C 43.24
V 1,309,411
10EMA 43.24
20EMA 43.24
60EMA 43.24
120EMA 43.24
250EMA 43.24